The true story of how a street cat named Bob changed the life of an alcoholic street musician in London came out in book form three years ago .
Now the movie version is coming — in which Bob is played (mostly) by Bob.
James Bowen’s autobiographical book telling the story of his struggle with addiction and of his life on the streets, in homeless shelters and in supported housing sold millions of copies.
Its focus was on the bond he formed with Bob after the cat found his way into Bowen’s room in a subsidized housing complex.
The pair went on become inseparable, winning fans across London.
Luke Treadaway stars as Bowen, a street musician overcoming a troubled childhood.
But in most of the scenes featuring Bob, that’s the real Bob you’ll be seeing.
The film is scheduled for release in early November.
Posted by John Woestendiek September 19th, 2016 under Muttsblog, videos.
Tags: a street cat named bob, addiction, alcoholism, animals, bob, book, busker, cat, cats, changed, homeless, james bowen, life, luke treadaway, movie, musician, pets
Thanks to the millennials, the percentage of American workplaces allowing dogs is increasing — up to 8 percent, from 5 percent five years ago.
NPR reported on the phenomena yesterday, citing examples of how employers — in an attempt to lure new employees by providing them with a low-cost benefit — are opening their doors to dogs.
Millennials (born between 1982 and 2004) are expected to make up half the work force by 2020, and they are expected to surpass baby boomers as the largest pet-owning generation around that same time.
Millennials tend to look at their pets “as practice families or substitute families and seem to be more verbal in their wants and needs for their pet and for making sure their pet is well tended and well cared for,” Bob Vetere, president and CEO of the American Pet Products Association, told CNBC, which reported on the increasing numbers of dogs in the workplace last fall.
“Employers are starting to realize that having a millennial bring … a pet to work, you wind up getting a more focused employee, you get someone more comfortable at the office and a person willing to work longer hours,” Vetere added.
Some companies, CNBC reported, go to greater lengths than others to make those dogs feel welcome, offering play areas, free pet training, pet walkers, pet health insurance, offsite pet sitters and grooming services.
More than 2,000 dogs are brought in by employees regularly to Amazon’s main campus in Seattle, where about 25,000 employees work. The company provides doggy treats at all of its reception desks and each of the nearly 30 buildings on the campus has spaces for pet exercise.
The NPR report focused on Replacements, that dog-friendly North Carolina china warehouse we told you about back in April.
It has about 400 employees, and about 30 animals who come to work with them regularly.
“… The interesting thing is that we have never had a pet break anything here,” said public relations manager Lisa Conklin. “We’ve had people, myself included, who have broken a number of these delicate pieces. But we have never to our knowledge had a pet break anything.”
Conklin says the pets-at-work policy costs the company nothing, and staff often say it’s their favorite perk.
On top of boosting morale and productivity, as studies have shown it does, it lets workers feel they are achieving a work-life balance — something a lot of baby boomers I know weren’t the best at.
Having a successful dogs-in-the-workplace program requires some planning, and some patience, and some resourcefulness, say those who have instituted them.
The NPR story cited the case of Buchanan Public Relations, a company located outside Philadelphia, where Lacey, a Rottweiler mix, was regularly being terrorized by Romeo, a toy poodle with “a bit of a Napoleon complex.”
Company owner Anne Buchanan — instead of reneging on the pets-at-work policy — hired a dog trainer who managed to restore workplace harmony.
(Photos: At top, Ginger, an English bulldog, at work with owner, Will Pisnieski, at Authentic Entertainment in Burbank, Calif., by Grant Hindsley / AP; bottom photo, Charlie rides along with employee Kim Headen at Replacements, by Peter Taylor / AP)
Posted by John Woestendiek August 10th, 2016 under Muttsblog.
Tags: amazon, animals, balance, cnbc, companies, dog, dogs, employees, employers, increasing, life, millennials, morale, news, npr, pets, productivity, replacements, reports, take your dog to work, work, workplace
Dogs have a knack for helping us accomplish our goals. Somehow, they seem to know what those goals are without ever being told. Maybe, they know our goals better than we do.
With no apparent effort, they can help us accomplish our missions … whatever the mission … even missions that are completely opposite from one another.
Dogs, for instance, can help us stick to a routine, or get us out of a rut. (Ace has done both for me.)
They can enlarge our circles of friends, and — at those times solitude might be best — keep it from getting too lonely. (Ace has done both of those, too.)
And they can both keep us young and show us how to grow old.
That last trick, I think, is particularly impressive.
Dogs, when you think about it, show us how to live our lives (in the moment, with abandon), cope with our maladies (with brave perseverance) and die our deaths (with grace and dignity).
Between the examples they offer, the similarities between our species and the uncovered secrets dogs may still hold, it’s no surprise that science and medicine and more than a few other fields of study are increasingly turning to them for answers.
What dogs have to teach us about living a healthy life — some of it obvious (if we pay attention), some of it suspected and undergoing research — was the subject of an article last month in AARP Magazine.
As it noted, dogs, as they continue to evolve alongside us, are increasingly mirroring us, right down to getting the same diseases and disorders.
“… This evolution is ongoing, a process scientists call convergence: Human and canine genes, shaped by the environment we share, are evolving in lockstep. Today, along with home security and leftover disposal, dogs confer a host of wellness benefits, especially to kids and older people,” the article’s author, David Dudley, wrote. “People with dogs sleep better, weigh less and get more exercise than dog-free peers.”
“And there are the less tangible perks, the ones cataloged in Marley & Me–style books. This burgeoning “dogoir” literary genre revolves around the reductive but basically correct idea that a dog is foremost an instrument of personal growth: It exists to ease your existential anxieties, impart lessons about love and friendship, and teach you how to be a better person.”
But as noted by Dudley, who weaves the lessons his dog Foghat taught him into the article, that’s just the beginning of what dogs might have to share.
He cites a couple of research projects as examples of the possible answers dogs may hold when it comes to aging.
Neuroscientist Elizabeth Head is studying elderly beagles at the University of Kentucky in an attempt to determine why, by age 6 or 7, they start showing signs of the microscopic beta-amyloid plaques that are the hallmarks of Alzheimer’s disease.
About a third of the beagles will succumb to canine cognitive dysfunction syndrome, about the same percentage of Americans over 85 who will get Alzheimer’s.
“It could be that living in our environment — our food, our water, our homes — has made dogs more vulnerable,” she says.
Head thinks dogs might hold the key to defeating it. Past studies, she notes, have demonstrated that an antioxidant-rich diet and “behavioral enrichment” — a course of memory drills and new-skills training — can significantly delay or diminish plaque development and memory impairments.
At the University of Washington, Daniel Promislow, an aging researcher (in both meanings of the phrase), has assembled a team to join in a Canine Longevity Consortium. Through a a grant from the National Institute on Aging, they’re working on the first national longitudinal study on aging in dogs, which will include looking at how dogs stay so seemingly happy and carefree as they advance in years.
On the downside, as we all know, they can relatively suddenly become frail, forgetful and sick — as was the case with Dudley’s dog, Foghat.
“…He entered his dotage in roaring good health. Around his 18th birthday, I Googled “oldest dog in the world,” because I started to wonder if he was closing in on a record. He was what gerontologists would call a successful ager.
“And then, seemingly overnight, he wasn’t. If you have to go — and you do — a swift slide into decrepitude is the preferred way. The phrase is “compression of morbidity,” when the infirmities of age are delayed until the bitter end. Still, it’s no picnic. The joints went first. He started limping after a vigorous bouncing-a-soccer-ball-off-his-nose session. Then he needed help climbing into the car or crawling under the bed, his favorite sleeping spot.”
As Foghat declined, Dudley wrote, his “senescence appeared as both a comfort and a warning of what awaits: Some fears and eccentricities will lift with the years; others will only deepen. One by one, the things you love to do become too difficult and slip out of your life.”
With his death, Dudley says, “I was struck by the strange new stillness — the foreign silence of a household without a dog. It was as if a machine that had been humming in the background for a long time had suddenly been switched off.”
Amid that silence, Dudley, like many other grieving dog owners, started quantifying what he learned from Foghat.
” …And now that I’m no longer young, and he’s dead, I’ll do my best to follow the path Foghat blazed into my life’s last half…” he wrote.
“So eat the best food you can afford. Go for a walk, even if it’s raining. Take a lot of naps. Keep your teeth clean and your breath fresh, so that the people you lick will not flinch. And when someone you love walks in through the door, even if it happens five times a day, go totally insane with joy.”
(Photo: Foghat, the author’s dog, in 1995 at age 1, left, and in 2012 at age 18; courtesy of David Dudley / AARP Magazine)
Posted by John Woestendiek February 16th, 2015 under Muttsblog.
Tags: aarp, acceptance, aging, alzheimers, animals, answers, cognition, david dudley, dignity, dogs, dogs as teachers, elderly, enjoy, examples, learning, learning from dogs, life, old, pets, research, secrets, solutions
Dog blogger and broadcaster Steve Friess says he’s not going to spend $5,000 to put his dog though chemotherapy that could extend his life a year or more — and he’s going to try not to feel bad about it.
Even when he says his final goodbye to Jack in what could be less than a month.
In late October, Friess noticed the dog he’d adopted nine years ago was getting lethargic, and that his weight had dropped from his usual 11 pounds to around eight.
A vet diagnosed that Jack had an aggressive form of lymphoma that was spreading quickly through his body.
Friess did some research, checking with friends, and vets, and friends who were vets: One of the latter urged him to “do the full chemo protocol ASAP!” It could send Jack into remission for nine months, or 12 months, or even longer.
Friess and his partner researched, debated and decided against chemotherapy — not because it would be all that rough on the dog physically (they handle it much better than we do). The main reason, he admits, is the money, which, he also admits, they just doesn’t have.
There will likely be those who second guess Freiss, or maybe try to lay a guilt trip on him: Take out a loan, hit up your friends, get a second (or third) job, launch an online fundraising campaign, let me be the first to donate.
We’ve become a nation of such overflowing compassion for dogs, with such promising new medical technologies, and such handy online fundraising tools at our beck and call, that it’s easy to lose sight that decisions about life and death — both ours and our dogs — are still our own, and that throwing in the towel, for financial reasons, or others, isn’t always a shameful choice.
We suspect Friess will receive some support for his decision, but will hear from many more questioning it. His decision to write about it, as he did in a post for Time.com, is brave, but also an open invitation to second-guessers. In any case, the decision on what’s best for Jack should be (and has been) made by the person who knows him best, and deserves to be respected
Friess, a freelance writer and co-host of The Petcast, said neither his advisers nor his vet seemed to be trying to make him feel guilty about his choice. But, as is the way with guilt trips, we often don’t need a tour guide. Feelings of shame can start as soon as we ask our vet the question Friess did:
“How much will it cost?”
For Friess, the estimate was a minimum of $5,000 — more than he and his partner had.
“(It) means we have about 30 days. The end will probably come in time for holidays … “We’ve received a lot of advice, both solicited and unwelcome, through social media. Nobody comes right out to say it, but the disappointment some express at our decision shows that they question our love for Jack. In an era when people spend big on animal clothes, artisanal foods and medical intervention, and when medical science makes it possible to spend $5,000 so Jack dies slightly later than sooner, there is pressure to go as far as we can.”
There’s one more twist. Friess and his partner are trying to adopt a human baby, and they’re working on saving the $15,000 fee for that.
“If that $5,000 could cure the cancer and restore Jack’s full life expectancy, maybe we’d do it,” he wrote. “Maybe. It certainly would be a tougher choice. But to buy a year during which we’d be waiting for his lymph nodes to resume their swell? We could endure the end stages either now or later.”
(Photo of Jack by Steve Friess)
Posted by John Woestendiek November 17th, 2014 under Muttsblog.
Tags: animals, cancer, care, chemotherapy, choices, costs, death, decisions, dog, dogs, financial, guilt, health care, jack, life, lymphoma, medical, options, ownership, pet, pets, shame, steve friess, technology, treatment, veterinary
Two University of Washington scientists think it might be possible to slow the aging process in canines and are launching a pilot study with 30 dogs to see if the drug rapamycin significantly extends their lifespans.
The researchers, using $200,000 in seed money from the University of Washington, plan to use pets, not laboratory animals, for the initial study, and recruit volunteer dogs — or at least dogs whose owners volunteer them — for larger scale studies in the future.
Daniel Promislow, an evolutionary geneticist, and Matthew Kaeberlein, a molecular biologist, say the study is aimed at determining whether rapamycin could lead to longer lives for dogs — as studies have shown is the case when it’s used on yeast, fruit flies, worms and mice.
“We’re not talking about doubling the healthy life spans of pets,” said Kaeberlein. “But at a minimum I would predict that you would get a 10 to 15 percent increase in average life span, and I think bigger effects are possible.”
In the pilot study, 30 large, middle-aged dogs will be involved — half receiving low doses of rapamycin, half receiving placebos.
The researchers say that subsequent studies will seek to enroll pet dogs from across the country.
Kaeberlein and Promislow hosted a meeting in Seattle last week where experts from across the country discussed the drug rapamycin and its possible effects on the health and longevity of dogs, the Seattle Times reported.
Currently used along with other medications to prevent rejection in organ-transplant patients, rapamycin has been called a promising anti-aging drug — though there have been no studies involving humans.
But almost 50 laboratory studies have shown that the compound can delay the onset of some diseases and degenerative processes and restore vigor to elderly animals, extending life spans by 9 to 40 percent.
Rapamycin functions, in part, by inactivating a protein that promotes cell growth. As a result, cells grow more slowly, which retards the spread of cancer.
Promislow, who has two elderly dogs of his own, noted that even if the drug doesn’t increase the life span of dogs, it could serve to keep them healthy longer. “We’re trying to understand why some dogs age better than others, and help all dogs age in a better way,” he said.
The drug has been shown to have serious side effects, including poor wound healing and an increased risk of diabetes, when used at the high doses required for organ transplant patients.
But the low doses used in anti-aging research with mice and other lab animals cause few side effects.
There have been no large-scale human trials. Studying how the drug affects dogs — who suffer many of the same old-age ailments as their masters — makes it possible to explore the possible benefits of rapamycin both more quickly and at a lesser cost.
If it does turn out to be a sort of fountain of youth — for dogs, humans, or both — the potential profits would be enormous.
“I think it’s worth a go, not just from what it can teach us about humans, but for the sake of the animals themselves,” said University of Alabama Biology Department Chairman Steven Austad, an expert in aging research who is not involved in the project. “It may not work in dogs, but if it did, boy, it’s going to be huge.”
According to the Seattle Times article, drug companies aren’t very interested in rapamycin because it’s no longer under patent.
But the researchers are hoping dog lovers, dog-food companies and some foundations might be willing to contribute to further research.
They’ve set up a website, dogagingproject.com,where people can donate and sign their dogs up to take part in the research.
“Given how I feel about my pets, I see this as a unique project where there’s a real potential for citizen science,” Kaeberlein said. “I think it would be great if pet owners who are really interested in improving the health of their animals would help fund this work.”
(Photos: UW scientists Matt Kaeberlein, with his dog Dobby, and Dan Promislow, with his dog Frisbee; by Steve Ringman / The Seattle Times)
Posted by John Woestendiek November 4th, 2014 under Muttsblog.
Tags: animals, anti aging, anti aging drug, biology, cancer, cells, citizen science, compound, Daniel Promislow, death, dog, dogs, drug, drugs, extending, fountain of youth, funding, geneticist, health, ifespan, laboratory, life, lifespans, lives, longer, Matthew Kaeberlein, molecular, pets, rapamycin, research, sickness, study, university of washington
A golden retriever named Bretagne is all over the Internet today — today being 9/11 — looking much grayer around the muzzle than she did in 2001 and being described as the only search and rescue dog at the World Trade Center who is still living.
Whether that’s accurate depends on how you define “living.”
Not to pick nits, but there’s another dog, a German shepherd named Trakr — said by some to have found the last human survivor of the World Trade Center attack — who lives on … in a way.
Trakr was cloned in 2009, after his owner, a police officer turned actor, won an essay contest seeking the world’s most “cloneworthy” dog.
It’s a long story, one you can read about in the book, “DOG, INC.,” which recounts how dog cloning became a commercial enterprise.
Here’s the short version: Trakr was the partner of James Symington, a Halifax, Nova Scotia, police officer. When Trakr was retired, Symington claimed him as his own. On Sept. 11, 2001, after seeing news reports, Symington, without authorization from his department, took Trakr to the World Trade Center.
There, as Symington recounts it, Trakr discovered Genelle Guzman buried in the rubble — the last survivor found.
Others dispute his account.
Symington later moved to California to pursue a career in acting, taking Trakr with him. When an American company called BioArts announced it was holding a “Golden Clone Giveaway,” Symington submitted an essay, and won.
BioArts footed the bill (about $150,000) and sent samples of Trakr’s DNA to South Korean veterinarian Hwang Woo-Suk, who was on the team at Seoul National University that produced the world’s first canine clone, Snuppy. He’d since been fired and opened his own laboratory, Sooam Biotech Research Foundation.
Trakr’s DNA was inserted into five “surrogate” egg cells, each of which was zapped with electricity and implanted into a different female dog.
In June 2009 five clone puppies were born and, a few months later, delivered to Symington. He named them Trustt, Solace, Valor, Prodigy, and Deja Vu, and said he planned to train them all as search as rescue dogs who would carry on Trakr’s legacy.
They seem to have fallen out of the limelight since then, and their Facebook page hasn’t been updated for a couple of years.
Earlier this year, the man who pushed dog cloning and sponsored the “Golden Clone Giveaway,” in an apparent turnaround, said cloning dogs — a service still offered in South Korea — was not a viable, profitable, or humane pursuit, noting that it took up to 80 dogs to clone just one.
Lou Hawthorne headed BioArts, and spearheaded the earliest (unsuccessful) efforts to clone dog at Texas A&M University. That research was funded by University of Phoenix founder John Sperling, who died last month.
While some of the main characters involved in dog cloning seem to be fading from public view, from Trakr’s clones to Sperling, dog cloning is not — Sooam Biotech is still carrying out clonings for customers who want duplicates of their dead or dying pets, at a price that has dropped to about $100,000.
But back to the dog who is in the news — Bretagne. She returned this week to the site of the former World Trade Center complex with her longtime handler and owner, where they were interviewed by Tom Brokaw for NBC’s Today Show.
Bretagne (pronounced “Brittany”) is one of eight finalists for the American Humane Association’s annual Hero Dog Awards, and later this month she’ll travel with her owner to Beverly Hills for the awards ceremony.
My hunch, and hope, is that Bretagne is not destined to be cloned, and that her owner realizes what many customers of dog cloning have not — every dog, and every person, is one of a kind. And one of a kind means one of a kind. That special something inside your dog can’t be re-created in a laboratory.
Posted by John Woestendiek September 11th, 2014 under Muttsblog.
Tags: 9-11, 911, animals, bioarts, bretagne, cloned, clones, cloning, death, dog, dog cloning, dog inc., dogs, golden clone giveaway, james symington, laboratory, last, life, living, pets, re-creating, rescue, search, search and rescue, September 11, sooam, surviving, trakr, world trade center
The Nevada Supreme Court — no stranger to such matters — will decide whether Onion, the Mastiff mix who killed his owner’s grandson on his first birthday, should live or die.
The court will hear arguments — 30 minutes worth, it has specified — on July 3 before deciding whether the city of Henderson should be allowed to kill the dog.
Another option has been offered by the Lexus Project, a New York-based organization that provides legal representation to dogs.
The Lexus Project intervened in the case and wants to gain custody of Onion, then send him to live at a secure sanctuary in Colorado.
The 120-pound mastiff-Rhodesian ridgeback mix killed Jeremiah Eskew-Shahan by biting him on the head the day of his first birthday party. Later that day, the owner turned Onion over to Henderson animal control officers, who planned to kill the dog in accordance with the city’s vicious-dog ordinance.
The city turned down the Lexus Project’s offer to take responsibility for the dog, and has fought its request to be awarded custody. Onion’s former owner now wants Lexus to have the dog, according to the Las Vegas Sun.
The court battle has been going on for a year now.
Last year, Clark County District Court Joanna Kishner ruled the city of Henderson could proceed with the dog’s execution.
The state Supreme Court issued a stay — it’s second in the case — until arguments could be heard.
Those will take place July 3 at 11:30 a.m.
Posted by John Woestendiek May 15th, 2013 under Muttsblog.
Tags: 120 pounds, animal control, animals, colorado, death, defense, dog, dogs, euthanasia, execution, henderson, jeremiah, legal, lexus project, life, mastiff, mix, nevada, onion, pets, rhodesian, ridgeback, safety, sanctuary, supreme court, the lexus project